| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Perioperative mortality and long-term survival following live kidney donation.
|
JAMA
|
2010
|
7.34
|
|
2
|
HIV infection is associated with an increased risk for lung cancer, independent of smoking.
|
Clin Infect Dis
|
2007
|
3.56
|
|
3
|
Hepatitis C and progression of HIV disease.
|
JAMA
|
2002
|
3.15
|
|
4
|
Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.
|
Gastroenterology
|
2008
|
3.00
|
|
5
|
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.
|
Hepatology
|
2002
|
2.71
|
|
6
|
Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
|
J Hepatol
|
2005
|
2.64
|
|
7
|
HIV incidence determination in the United States: a multiassay approach.
|
J Infect Dis
|
2012
|
2.47
|
|
8
|
Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.
|
AIDS
|
2005
|
2.34
|
|
9
|
Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay.
|
AIDS
|
2014
|
2.18
|
|
10
|
Neighborhood poverty and injection cessation in a sample of injection drug users.
|
Am J Epidemiol
|
2010
|
2.07
|
|
11
|
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
|
AIDS
|
2007
|
1.92
|
|
12
|
The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort.
|
AIDS
|
2013
|
1.92
|
|
13
|
Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resource-limited settings?
|
Clin Infect Dis
|
2013
|
1.92
|
|
14
|
Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.
|
JAMA
|
2012
|
1.88
|
|
15
|
Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India.
|
Clin Infect Dis
|
2007
|
1.83
|
|
16
|
High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.
|
AIDS Behav
|
2012
|
1.83
|
|
17
|
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.
|
Ann Intern Med
|
2013
|
1.82
|
|
18
|
High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
|
J Acquir Immune Defic Syndr
|
2008
|
1.81
|
|
19
|
Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.
|
Clin Infect Dis
|
2009
|
1.80
|
|
20
|
End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004.
|
AIDS
|
2007
|
1.61
|
|
21
|
High HIV burden among people who inject drugs in 15 Indian cities.
|
AIDS
|
2015
|
1.60
|
|
22
|
The effect of HIV infection on overdose mortality.
|
AIDS
|
2005
|
1.58
|
|
23
|
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.
|
J Infect Dis
|
2010
|
1.58
|
|
24
|
Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus.
|
Gastroenterology
|
2010
|
1.53
|
|
25
|
Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users.
|
AIDS
|
2013
|
1.49
|
|
26
|
Frailty, HIV infection, and mortality in an aging cohort of injection drug users.
|
PLoS One
|
2013
|
1.46
|
|
27
|
The relationship of physical performance with HIV disease and mortality.
|
AIDS
|
2014
|
1.46
|
|
28
|
The effect of neighborhood deprivation and residential relocation on long-term injection cessation among injection drug users (IDUs) in Baltimore, Maryland.
|
Addiction
|
2011
|
1.46
|
|
29
|
Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir.
|
AIDS
|
2004
|
1.44
|
|
30
|
Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.
|
J Int AIDS Soc
|
2012
|
1.44
|
|
31
|
The emerging HIV epidemic among men who have sex with men in Tamil Nadu, India: geographic diffusion and bisexual concurrency.
|
AIDS Behav
|
2010
|
1.43
|
|
32
|
Variations in sexual risks in drug users: emerging themes in a behavioral context.
|
Curr HIV/AIDS Rep
|
2008
|
1.43
|
|
33
|
Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users.
|
AIDS
|
2012
|
1.41
|
|
34
|
Discordance between CD4+ T-lymphocyte counts and percentages in HIV-infected persons with liver fibrosis.
|
Clin Infect Dis
|
2012
|
1.41
|
|
35
|
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
|
Ann Intern Med
|
2013
|
1.41
|
|
36
|
Non-fatal overdose and subsequent drug treatment among injection drug users.
|
Drug Alcohol Depend
|
2005
|
1.39
|
|
37
|
Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts.
|
AIDS Res Ther
|
2007
|
1.39
|
|
38
|
The impact of HIV and high-risk behaviours on the wives of married men who have sex with men and injection drug users: implications for HIV prevention.
|
J Int AIDS Soc
|
2010
|
1.35
|
|
39
|
Nonstructured treatment interruptions among injection drug users in Baltimore, MD.
|
J Acquir Immune Defic Syndr
|
2009
|
1.34
|
|
40
|
Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users.
|
J Acquir Immune Defic Syndr
|
2010
|
1.33
|
|
41
|
Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy.
|
Clin Infect Dis
|
2011
|
1.29
|
|
42
|
Knowledge, attitudes, and practices of antiretroviral therapy among HIV-infected adults attending private and public clinics in India.
|
AIDS Patient Care STDS
|
2007
|
1.29
|
|
43
|
HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users.
|
Clin Infect Dis
|
2011
|
1.28
|
|
44
|
Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users.
|
Addict Behav
|
2010
|
1.27
|
|
45
|
Mortality risk among new onset injection drug users.
|
Addiction
|
2004
|
1.23
|
|
46
|
Beyond surveillance: a role for respondent-driven sampling in implementation science.
|
Am J Epidemiol
|
2013
|
1.20
|
|
47
|
Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City.
|
Addict Behav
|
2011
|
1.20
|
|
48
|
The profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions.
|
Subst Use Misuse
|
2010
|
1.18
|
|
49
|
Response to overdose among injection drug users.
|
Am J Prev Med
|
2006
|
1.18
|
|
50
|
Association between obstructive lung disease and markers of HIV infection in a high-risk cohort.
|
Thorax
|
2011
|
1.16
|
|
51
|
Mortality among injection drug users in Chennai, India (2005-2008).
|
AIDS
|
2009
|
1.09
|
|
52
|
Trajectories of injection drug use over 20 years (1988-2008) in Baltimore, Maryland.
|
Am J Epidemiol
|
2011
|
1.09
|
|
53
|
Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.
|
Hepatology
|
2014
|
1.08
|
|
54
|
Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.
|
Gastroenterology
|
2012
|
1.06
|
|
55
|
Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV.
|
BMC Pulm Med
|
2010
|
1.06
|
|
56
|
The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD.
|
Drug Alcohol Depend
|
2013
|
1.03
|
|
57
|
Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections.
|
J Acquir Immune Defic Syndr
|
2013
|
1.02
|
|
58
|
CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection.
|
J Infect Dis
|
2007
|
1.01
|
|
59
|
Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution.
|
AIDS
|
2009
|
1.00
|
|
60
|
High HIV prevalence and incidence among MSM across 12 cities in India.
|
AIDS
|
2015
|
0.99
|
|
61
|
Correlates of unsafe syringe acquisition and disposal among injection drug users in Baltimore, Maryland.
|
Subst Use Misuse
|
2005
|
0.98
|
|
62
|
Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.
|
AIDS
|
2012
|
0.97
|
|
63
|
A prospective study of alcohol consumption and HIV acquisition among injection drug users.
|
AIDS
|
2011
|
0.96
|
|
64
|
Impact of diabetes on mortality among patients with community-acquired bacteremia.
|
J Infect
|
2007
|
0.95
|
|
65
|
HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.
|
J Clin Microbiol
|
2013
|
0.95
|
|
66
|
Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users.
|
Int J Chron Obstruct Pulmon Dis
|
2011
|
0.95
|
|
67
|
Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.
|
J Virol
|
2007
|
0.94
|
|
68
|
Determinants of alcohol consumption in HIV-uninfected injection drug users.
|
Drug Alcohol Depend
|
2010
|
0.92
|
|
69
|
The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India.
|
BMC Public Health
|
2011
|
0.92
|
|
70
|
Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART).
|
AIDS Behav
|
2015
|
0.91
|
|
71
|
Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users.
|
J Clin Microbiol
|
2004
|
0.91
|
|
72
|
Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.
|
Clin Infect Dis
|
2007
|
0.91
|
|
73
|
Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
|
Eur J Gastroenterol Hepatol
|
2015
|
0.90
|
|
74
|
The relationship between social network factors, HIV, and Hepatitis C among injection drug users in Chennai, India.
|
Drug Alcohol Depend
|
2011
|
0.90
|
|
75
|
Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection.
|
J Hepatol
|
2011
|
0.90
|
|
76
|
Estimating the effects of multiple time-varying exposures using joint marginal structural models: alcohol consumption, injection drug use, and HIV acquisition.
|
Epidemiology
|
2012
|
0.89
|
|
77
|
Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India.
|
Am J Epidemiol
|
2010
|
0.89
|
|
78
|
Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users.
|
Hepatology
|
2012
|
0.89
|
|
79
|
Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis.
|
PLoS One
|
2011
|
0.88
|
|
80
|
Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users.
|
J Acquir Immune Defic Syndr
|
2008
|
0.87
|
|
81
|
HIV and proteinuria in an injection drug user population.
|
Clin J Am Soc Nephrol
|
2010
|
0.87
|
|
82
|
Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women.
|
Sex Transm Dis
|
2009
|
0.87
|
|
83
|
HIV and COPD: impact of risk behaviors and diseases on quality of life.
|
Qual Life Res
|
2010
|
0.86
|
|
84
|
Application of space-time scan statistics to describe geographic and temporal clustering of visible drug activity.
|
J Urban Health
|
2014
|
0.86
|
|
85
|
Sensitivity changes over the course of infection increases the likelihood of resistance against fusion but not CCR5 receptor blockers.
|
AIDS Res Hum Retroviruses
|
2012
|
0.84
|
|
86
|
Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection.
|
Antivir Ther
|
2012
|
0.83
|
|
87
|
HIV Infection Is Associated With Increased Risk for Acute Exacerbation of COPD.
|
J Acquir Immune Defic Syndr
|
2015
|
0.82
|
|
88
|
Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland.
|
Addict Behav
|
2013
|
0.82
|
|
89
|
A Brief Screening Tool to Assess the Risk of Contracting HIV Infection Among Active Injection Drug Users.
|
J Addict Med
|
2015
|
0.80
|
|
90
|
The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.
|
Am J Epidemiol
|
2014
|
0.79
|
|
91
|
Hepatitis C virus infection is not an independent risk factor for obstructive lung disease.
|
COPD
|
2013
|
0.78
|
|
92
|
Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons.
|
AIDS
|
2010
|
0.78
|
|
93
|
Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals.
|
AIDS
|
2016
|
0.78
|
|
94
|
Immunologic response among HIV-infected patients enrolled in a graduated cost-recovery programme of antiretroviral therapy delivery in Chennai, India.
|
Indian J Med Res
|
2013
|
0.77
|
|
95
|
Impact of generic antiretroviral therapy (ART) and free ART programs on time to initiation of ART at a tertiary HIV care center in Chennai, India.
|
AIDS Care
|
2012
|
0.77
|
|
96
|
Altered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression.
|
J Acquir Immune Defic Syndr
|
2015
|
0.76
|
|
97
|
Injection drug network characteristics are important markers of HIV risk behavior and lack of viral suppression.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
98
|
Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans.
|
J Infect Dis
|
2013
|
0.75
|
|
99
|
Uptake and Acceptability of Information and Communication Technology in a Community-Based Cohort of People Who Inject Drugs: Implications for Mobile Health Interventions.
|
JMIR Mhealth Uhealth
|
2015
|
0.75
|